SIM0680
/ Simcere
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 26, 2025
SIM0680, a potent antibody-drug conjugate for the treatment of solid tumors expressing ENPP3
(AACR 2025)
- "Our findings underscore the potential of targeting the apically restricted tumor antigen ENPP3 with antibody therapy and support clinical development of SIM0680 as a novel therapeutic modality for treatment of ENPP3-positive solid tumors."
Colorectal Cancer • Hematological Malignancies • Hepatocellular Cancer • Leukemia • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1